ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 42866405

Beyond tumor biology: can host nutritional status refine prediction of early recurrence after pancreatic cancer surgery?

Okabayashi T. Gland Surg, 2026.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Beyond tumor biology: can host nutritional status refine prediction of early recurrence after pancreatic cancer surgery? Papers, record 42866405. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42866405

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Beyond tumor biology: can host nutritional status refine prediction of early recurrence after pancreatic cancer surgery?
Journal
Gland Surg
Year
2026
Publication types
Editorial, Comment
Revised in PubMed
2026-10-13

Source PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Okabayashi TTakehirohttps://orcid.org/0000-0002-4829-4306

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on42,591,648Low prealbumin predicts early recurrence after pancreatic cancer surgery: a retrospective cohort study.https://conductscience.org/library/papers/42591648

Source PubMed

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140,945,523
Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial.
Lancet Oncol2025https://conductscience.org/library/papers/40945523PubMed
242,591,648Low prealbumin predicts early recurrence after pancreatic cancer surgery: a retrospective cohort study.Gland Surg2026https://conductscience.org/library/papers/42591648PubMed
326,909,576Genomic analyses identify molecular subtypes of pancreatic cancer.Nature2016https://conductscience.org/library/papers/26909576PubMed
427,158,978Pancreatic cancer.Nat Rev Dis Primers2016https://conductscience.org/library/papers/27158978PubMed
538,836,800Preoperative low skeletal muscle mass index assessed using L3-CT as a prognostic marker of clinical outcomes in pancreatic cancer patients undergoing surgery: a systematic review and meta-analysis.Int J Surg2024https://conductscience.org/library/papers/38836800PubMed
634,144,781Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆.ESMO Open2021https://conductscience.org/library/papers/34144781PubMed
741,044,427The tumour microenvironment in pancreatic cancer - new clinical challenges, but more opportunities.Nat Rev Clin Oncol2025https://conductscience.org/library/papers/41044427PubMed
840,957,230ESPEN guideline on clinical nutrition in surgery - Update 2025.Clin Nutr2025https://conductscience.org/library/papers/40957230PubMed
931,344,989The role of pretreatment prognostic nutritional index in esophageal cancer: A meta-analysis.J Cell Physiol2019https://conductscience.org/library/papers/31344989PubMed
1037,572,593Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review and meta-analysis.Cancer Treat Rev2023https://conductscience.org/library/papers/37572593PubMed

1 to 10 of 20

See all 20 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42866405

GET https://conductscience.org/api/papers/v1/42866405/authors

API referenceFor AI assistants